Skip to main content
. 2023 Apr 21;270(8):3830–3838. doi: 10.1007/s00415-023-11739-6

Table 1.

Demographic, anthropometric and clinical characteristics of participants in the 2013–2014 National Health and Nutrition Examination Survey according to quartiles of serum neurofilament light chain (sNfL) levels

sNfL quartiles, pg/mL p-Trend
2.8–8.2 8.3–12.3 12.4–19.1  ≥ 19.2
Age category (years)  < 0.001
 20–34 266 (56.9) 143 (30.2) 88 (19.6) 44 (10.6)
 35–44 152 (27.3) 119 (24.0) 65 (14.9) 71 (13.9)
 45–54 73 (12.0) 122 (22.3) 114 (24.0) 74 (17.1)
 55–64 32 (3.7) 100 (17.3) 145 (24.5) 143 (29.6)
 65–75 1 (0.1) 37 (6.3) 99 (17.0) 182 (28.9)
Sex 0.002
 Male 215 (42.5) 254 (50.2) 251 (48.5) 270 (54.2)
 Female 309 (57.5) 267 (49.8) 260 (51.5) 244 (45.8)
Race-ethnicity (%) 0.001
 Non-Hispanic white 196 (54.0) 212 (62.7) 248 (71.9) 254 (72.5)
 Hispanic 146 (22.5) 126 (15.3) 110 (12.5) 105 (10.3)
 Non-Hispanic black 94 (14.0) 110 (14.4) 70 (8.1) 99 (11.4)
 Non-Hispanic Asian 67 (6.0) 65 (5.9) 72 (6.1) 43 (3.5)
 Other 21 (3.6) 8 (1.7) 11 (1.4) 13 (2.3)
Education 0.137
 High school or less 212 (36.1) 227 (37.2) 200 (33.5) 242 (36.3)
 Some college 176 (34.7) 149 (30.4) 155 (30.8) 172 (38.4)
 College or above 135 (29.3) 144 (32.4) 156 (35.8) 99 (25.3)
Cigarette smoke 0.023
 Never 329 (64.1) 309 (58.5) 266 (52.3) 250 (49.7)
 Former 83 (15.7) 108 (21.8) 133 (25.3) 136 (27.4)
 Current 112 (20.2) 104 (19.7) 111 (22.3) 128 (23.0)
BMI (kg/m2) 29.9 (0.4) 28.9 (0.4) 28.6 (0.4) 30.1 (0.4) 0.949
eGFR (mL/min) 109.0 (0.8) 99.3 (0.9) 91.1 (1.0) 84.2 (1.1)  < 0.001
Diabetes 22 (3.2) 38 (6.4) 77 (12.7) 137 (20.4)
CVD (%) 5 (0.7) 20 (4.7) 44 (7.2) 79 (13.6)  < 0.001
Stroke 1 (0.2) 5 (1.6) 19 (3.7) 26 (4.4) 0.008

Data are expressed as numbers (weighted proportions) for categorical variables and as weighted means (Standard Error (SE)) for continuous variables. p-values for trend in participants’ features were computed using weighted linear and logistic regression for continuous and categorical variables, respectively

BMI body mass index; CVD cardiovascular disease; HbA1c hemoglobin A1c; HDL high density lipoprotein